Milk of Magnesia

Drug Overview

In the foundational practice of Gastroenterology, managing acute and chronic alterations in bowel habits and gastric acidity is a cornerstone of patient care. Milk of Magnesia is a highly reliable, inorganic small-molecule therapy that has been utilized for decades to provide rapid and effective relief for patients suffering from gastrointestinal discomfort. Classified as a Saline Laxative and an Antacid, this medication plays a crucial role in restoring normal digestive transit and neutralizing excess stomach acid.

For patients dealing with the uncomfortable and often painful symptoms of delayed bowel movements or acid reflux, this medication offers an accessible, fast-acting solution. It is typically administered as an oral liquid suspension or a chewable tablet, making it highly adaptable for various patient needs.

• Generic Name: Magnesium hydroxide
• US Brand Names: Phillips’ Milk of Magnesia, Pedia-Lax Chewable, Dulcolax Liquid
• Drug Category: Gastroenterology
• Drug Class: Saline Laxative / Antacid
• Route of Administration: Oral (Liquid suspension, chewable tablet)
• FDA Approval Status: Fully FDA-approved as an over-the-counter (OTC) medication for the treatment of occasional constipation and acid indigestion.

What Is It and How Does It Work? (Mechanism of Action)

Milk of Magnesia operates through two distinct physiological mechanisms, depending on the dosage and the specific gastrointestinal environment it interacts with. Because it is an inorganic Small Molecule, it does not rely on complex liver metabolism or systemic absorption to exert its primary effects; rather, it works directly within the lumen of the stomach and the intestines.

As an Antacid (Gastric Acid Neutralization):
At low doses, magnesium hydroxide directly neutralizes gastric hydrochloric acid, forming magnesium chloride and water. This reaction rapidly raises gastric pH, reduces mucosal irritation, and provides fast symptomatic relief from heartburn and acid indigestion.

As a Saline Laxative (Osmotic Fluid Retention):
At higher doses, poorly absorbed magnesium ions persist in the intestinal lumen, creating a hyperosmotic gradient that draws water into the bowel. This increases stool hydration and intraluminal volume, distends the bowel wall, activates mechanoreceptors, and triggers enteric nervous system–mediated peristalsis to promote evacuation.

FDA-Approved Clinical Indications

Milk of Magnesia is indicated for specific, symptom-driven gastrointestinal complaints. It is utilized to restore mechanical and chemical harmony in the digestive tract.

• Primary Gastroenterology Indications:
  • Occasional Constipation: Used as a short-term treatment to induce a bowel movement, typically yielding results within 30 minutes to 6 hours. It works to restore digestive health by clearing impacted stool and relieving colonic distension.
  • Acid Indigestion, Heartburn, and Sour Stomach: Used to rapidly neutralize excess gastric acid, reducing mucosal damage and alleviating the sharp, burning discomfort associated with mild, episodic acid reflux.
• Other Approved & Off-Label Uses:
  • Gastroesophageal Reflux Disease (GERD): Used as a supplemental, short-acting rescue antacid for breakthrough symptoms in patients already on maintenance therapies.
  • Bowel Preparation (Off-Label): Occasionally utilized as part of a multi-step osmotic bowel cleansing regimen prior to endoscopic procedures or abdominal surgeries, though magnesium citrate is more standardly utilized for this purpose.

Dosage and Administration Protocols

Milk of Magnesia should be taken with a full glass of water (at least 8 ounces), especially when used as a laxative, to facilitate the osmotic drawing of fluid into the bowel and prevent systemic dehydration.

Dose Adjustments and Special Populations:

• Renal Insufficiency: Magnesium is excreted exclusively by the kidneys. In patients with severe renal impairment (creatinine clearance less than 30 mL/min), Milk of Magnesia should be heavily restricted or entirely avoided. The inability to clear absorbed trace magnesium can lead to dangerous, life-threatening hypermagnesemia.
• Pediatric Patients: Dosing is strictly weight- and age-dependent. Children under 12 typically require 15 mL to 30 mL for laxative effects, while children under 6 should only receive the medication under direct pediatric supervision.
• Elderly Patients: Older adults should start at the lowest effective dose to prevent sudden dehydration, severe electrolyte shifts, and subsequent falls related to urgency.

Dosage must be individualized by a qualified healthcare professional.

Clinical Efficacy and Research Results

While Milk of Magnesia is a legacy medication, contemporary clinical reviews from 2020 to 2026 continue to validate its high efficacy as a first-line osmotic agent. In the management of acute constipation, studies confirm that weight-appropriate doses of magnesium hydroxide produce a spontaneous bowel movement in 80% to 85% of patients within the expected 6-hour window.

Clinical research evaluating patient-reported outcomes using the Patient Assessment of Constipation Symptoms (PAC-SYM) scale demonstrates a 40% to 50% improvement in stool consistency scores and a significant reduction in the physical strain required for defecation. For its antacid properties, gastric pH monitoring studies show that liquid magnesium hydroxide elevates gastric pH above 4.0 within 15 to 30 minutes of ingestion, providing a faster onset of symptom relief compared to standard H2-receptor antagonists, though the duration of relief is notably shorter (typically 1 to 2 hours).

Safety Profile and Side Effects

There are no black box warnings for Milk of Magnesia. However, because it alters fluid and electrolyte dynamics, it must be used with clinical caution, particularly in vulnerable populations.

Common Side Effects (>10%)

• Gastrointestinal: Watery diarrhea, mild abdominal cramping, nausea, and an unpleasant chalky aftertaste.
• Fluid Volume: Mild, transient dehydration resulting from the osmotic shift of bodily fluids into the bowel lumen.

Serious Adverse Events

• Hypermagnesemia: A severe electrolyte imbalance characterized by an accumulation of magnesium in the blood. This occurs almost exclusively in patients with impaired kidney function or those who chronically overuse the medication. Symptoms include profound muscle weakness, severe lethargy, dangerously low blood pressure, and respiratory depression.
• Severe Electrolyte Imbalances: Overuse can lead to the systemic depletion of other critical electrolytes, such as calcium and potassium, leading to cardiac arrhythmias.
• Bowel Dependence: Chronic use of laxatives can impair the natural motility of the colon, leading to a reliance on the medication to produce a bowel movement.

Management Strategies: Patients should be explicitly instructed to stay heavily hydrated while taking this medication. If severe diarrhea or signs of muscle weakness occur, the medication must be discontinued immediately, and serum electrolyte panels should be drawn.

Connection to Mucosal Immunology and Microbiome Research

Bowel transit time is increasingly recognized as a key determinant of microbiome stability and mucosal immune signaling. Milk of Magnesia, through osmotic acceleration of transit, can transiently reduce luminal bacterial density and SCFA availability, potentially weakening tight junction integrity and colonization resistance. When used as an antacid, it may also raise gastric pH and reduce the stomach’s antimicrobial barrier, permitting greater survival of ingested bacteria into the small intestine. Ongoing research is evaluating whether chronic exposure to these effects can shift GALT-mediated tolerance and alter long-term mucosal barrier dynamics

Disclaimer: The research discussed regarding the effects of magnesium hydroxide on mucosal immunology and the gut microbiome is currently exploratory and based on emerging scientific investigations. These findings are not yet fully established or applicable to routine clinical practice or professional medical decision-making. 

Patient Management and Clinical Protocols

Safe and effective patient management requires a thorough understanding of the patient’s baseline physiology and the exact nature of their gastrointestinal distress.

Pre-treatment Assessment

• Baseline Diagnostics: A careful physical examination of the abdomen is required. The physician must definitively rule out gastrointestinal obstruction, appendicitis, or a perforated bowel, as stimulating a blocked bowel with a laxative can cause catastrophic tearing.
• Organ Function: Assessing renal clearance via an estimated Glomerular Filtration Rate (eGFR) is the single most critical pre-treatment check. Patients with failing kidneys cannot safely process this medication.
• Screening: Review the patient’s current medication list. Milk of Magnesia can bind to and prevent the absorption of numerous other medications, including certain antibiotics (like tetracyclines and fluoroquinolones) and bisphosphonates.

Monitoring and Precautions

• Vigilance: Monitor the patient for the resolution of symptoms. If constipation persists for more than seven continuous days despite treatment, the medication should be stopped, and the patient must undergo further diagnostic testing, such as a colonoscopy, to rule out colorectal malignancy or structural strictures.
• Lifestyle: Emphasize that laxatives are temporary solutions. Long-term digestive health requires robust dietary modifications, including increased dietary fiber intake, adequate daily water consumption, and regular physical exercise to naturally promote peristalsis.
• “Do’s and Don’ts” list:
  • DO drink at least one full 8-ounce glass of water with every dose to prevent dehydration.
  • DO shake the liquid suspension vigorously before pouring to ensure the active ingredient is evenly distributed.
  • DO separate the intake of this medication from your other prescription drugs by at least two hours to prevent absorption interference.
  • DON’T use this medication for more than seven consecutive days without explicit approval from your gastroenterologist.
  • DON’T take this medication if you are currently experiencing severe, undiagnosed stomach pain, nausea, or active vomiting.

Legal Disclaimer

The medical information provided in this comprehensive guide is for educational and informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. It should not be used as a substitute for direct consultation with a specialized Gastroenterologist or a qualified healthcare provider. Always seek the advice of your physician regarding any questions you may have about a medical condition, new therapies, or adjustments to your current treatment protocols